Stieglitz, Elliot <br/><br/>
Genome-wide DNA methylation is predictive of outcome in juvenile myelomonocytic leukemia.  [electronic resource] 

 -  Nature communications  12 2017 
 - 2127 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Observational Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2041-1723 
<br/><br/><label>Standard No.: </label>10.1038/s41467-017-02178-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--therapeutic use<br/>Biopsy<br/>Child<br/>Child, Preschool<br/>DNA Methylation<br/>Disease-Free Survival<br/>Female<br/>Genome, Human--genetics<br/>Hematopoietic Stem Cell Transplantation<br/>Humans<br/>Infant<br/>Kaplan-Meier Estimate<br/>Leukemia, Myelomonocytic, Juvenile--blood<br/>Male<br/>Monocytes<br/>Mutation<br/>Neoplasm Regression, Spontaneous--genetics<br/>Prognosis<br/>Prospective Studies